GPR3
Basic information
Region (hg38): 1:27392622-27395814
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 0 |
Variants in GPR3
This is a list of pathogenic ClinVar variants found in the GPR3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-27393874-C-T | not specified | Likely benign (Oct 16, 2024) | ||
1-27393901-G-A | not specified | Uncertain significance (Oct 24, 2023) | ||
1-27393905-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
1-27393923-C-T | not specified | Uncertain significance (Sep 09, 2024) | ||
1-27393965-G-A | not specified | Uncertain significance (May 10, 2024) | ||
1-27393980-T-C | not specified | Uncertain significance (May 06, 2022) | ||
1-27394048-G-A | not specified | Uncertain significance (Jun 05, 2024) | ||
1-27394100-T-A | not specified | Uncertain significance (Aug 26, 2024) | ||
1-27394105-A-C | not specified | Uncertain significance (Nov 21, 2022) | ||
1-27394115-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
1-27394198-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
1-27394286-G-T | not specified | Uncertain significance (Sep 22, 2022) | ||
1-27394504-G-T | not specified | Uncertain significance (Jan 30, 2024) | ||
1-27394514-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
1-27394673-T-A | not specified | Uncertain significance (Sep 09, 2024) | ||
1-27394709-T-C | not specified | Uncertain significance (Jul 11, 2023) | ||
1-27394725-G-C | not specified | Uncertain significance (Jul 11, 2023) | ||
1-27394766-G-A | not specified | Uncertain significance (Dec 05, 2024) | ||
1-27394782-T-A | not specified | Uncertain significance (Jun 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR3 | protein_coding | protein_coding | ENST00000374024 | 1 | 3171 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000263 | 0.559 | 125731 | 0 | 16 | 125747 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.944 | 161 | 198 | 0.811 | 0.0000121 | 2069 |
Missense in Polyphen | 38 | 55.772 | 0.68135 | 635 | ||
Synonymous | -0.361 | 93 | 88.7 | 1.05 | 0.00000552 | 780 |
Loss of Function | 0.512 | 6 | 7.52 | 0.798 | 3.26e-7 | 84 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000229 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Orphan receptor with constitutive G(s) signaling activity that activate cyclic AMP. Has a potential role in modulating a number of brain functions, including behavioral responses to stress (By similarity), amyloid-beta peptide generation in neurons and neurite outgrowth (By similarity). Maintains also meiotic arrest in oocytes (By similarity). {ECO:0000250, ECO:0000269|PubMed:19213921}.;
- Pathway
- GPCRs, Class A Rhodopsin-like
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.439
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.641
- hipred
- N
- hipred_score
- 0.459
- ghis
- 0.430
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.556
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr3
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- adenylate cyclase-activating G protein-coupled receptor signaling pathway;regulation of meiotic nuclear division;positive regulation of cold-induced thermogenesis
- Cellular component
- integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;protein binding